Amy Gravino is a certified autism specialist and professional public speaker and writer whose work focuses on sex and sexuality among autistic people. As founder and president of A.S.C.O.T. Consulting, she offers autism consulting and college coaching services for individuals on the spectrum, mentoring services for young adults with autism, and professional presentations for conferences, autism events, schools and professional development workshops. She has an M.A. in applied behavior analysis from Caldwell University in New Jersey. Gravino is working on a book, “The Naughty Autie,” a memoir of her experiences with relationships as a woman on the autism spectrum.
Amy Gravino
Autism consultant
From this contributor
Why it’s time to be honest about autistic women and sex
Misinformation about autistic women and sex is common in the scientific community. A study published this year is a case in point.
Why it’s time to be honest about autistic women and sex
Explore more from The Transmitter
SHANK3 deficiency and behavior in mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.
SHANK3 deficiency and behavior in mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.
Remembering Mark Hallett, leader in transcranial magnetic stimulation
The long-time NINDS researcher, best known for studying movement disorders, has died at age 82.
Remembering Mark Hallett, leader in transcranial magnetic stimulation
The long-time NINDS researcher, best known for studying movement disorders, has died at age 82.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.